Stay updated on Masitinib Efficacy and Safety in ALS Clinical Trial
Sign up to get notified when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.

Latest updates to the Masitinib Efficacy and Safety in ALS Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated to v3.2.0 and added a government funding/operating-status notice; removed the old v3.1.0 reference.SummaryDifference3%
- Check18 days agoChange DetectedUpdate to version v3.1.0 with an added contact number; several safety/topic keywords removed (potential scope shift in content).SummaryDifference0.4%
- Check25 days agoChange Detected- Added a timestamp label: Last Update Posted (Estimated) - Removed the exact phrase: Last Update Posted Overall: The page now signals an estimated last update, replacing the previous explicit label.SummaryDifference0.0%
- Check32 days agoChange DetectedVersion bumped to v3.0.2 with new 2025 dates and IPD planning entries added. Older 2023 data and v3.0.1 references were removed, and a manufacturing-origin note (US) was added.SummaryDifference3%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as resources related to Amyotrophic Lateral Sclerosis. Notably, the revision number has been updated to v3.0.0.SummaryDifference6%
Stay in the know with updates to Masitinib Efficacy and Safety in ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Masitinib Efficacy and Safety in ALS Clinical Trial page.